Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Elevation Oncology, Inc. | 12,311 | reported | 15 Feb 2025 | tx 10+947,500−22,689 |
| OnKure Therapeutics, Inc. | 7,650 | reported | 28 May 2025 | tx 2+22,950 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2025 | GRANT_AWARD | OnKure Therapeutics, Inc. | 7,650 | 0.00 USD | deriv |
| 15 Feb 2025 | TAX_WITHHOLDING | Elevation Oncology, Inc. | 5,189 | 0.67 USD | |
| 15 Feb 2025 | EXERCISE | Elevation Oncology, Inc. | 17,500 | — | |
| 15 Feb 2024 | EXERCISE | Elevation Oncology, Inc. | 17,500 | 0.00 USD | deriv |
| 15 Feb 2025 | GRANT_AWARD | Elevation Oncology, Inc. | 275,000 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 15,300 | 0.00 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | Elevation Oncology, Inc. | 70,000 | 0.00 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | Elevation Oncology, Inc. | 225,000 | 0.00 USD | deriv |
| 15 Feb 2023 | GRANT_AWARD | Elevation Oncology, Inc. | 130,000 | 0.00 USD | deriv |
| 06 Jan 2023 | GRANT_AWARD | Elevation Oncology, Inc. | 130,000 | 0.00 USD | deriv |
| 14 Feb 2022 | GRANT_AWARD | Elevation Oncology, Inc. | 60,000 | 0.00 USD | deriv |
| 19 Oct 2021 | GRANT_AWARD | Elevation Oncology, Inc. | 40,000 | 0.00 USD | deriv |